Evidence map›Paper›PMID 40294521›Full record

ArticlePLoS medicine2025

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials.

An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz, Gary S Collins, Ruth Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A Berlin and 29 more

3 registry-linked trialsAbstract readConsensus Statement
In one paragraph

Article in PLoS medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07125404 nanot yet recruitingnot on this map

Effectiveness of Low-Level Laser Auriculotherapy in the Treatment of Myogenic Temporomandibular Disorders and Anxiety: A Randomized Clinical Trial

TypeinterventionalSponsorQuiropraxia y EquilibrioRan2025 to 2026Enrolled32ConditionsTemporomandibular Disorder, Anxiety StateArmsLow-level laser auriculotherapy (LLLT-AT), Sham Low-level laser auriculotherapy (sham LLLT-AT), Myofascial release
NCT07175701 narecruitingnot on this map

Effects of Ultra-processed Food Reduction Intervention on Postprandial Glucose and Glycemic Variability in Korean Young Adults: Study Protocol for the ULTRA-CGM Randomized Controlled Trial

TypeinterventionalSponsorKorea UniversityRan2025 to 2026Enrolled50ConditionsPostprandial Glucose, Glucose Levels, HyperglycemiasArms40-minute one-on-one dietary counseling and nutrition education aimed at reducing ultra-processed food consumption, Standard dietary counseling and nutrition education based on national guidelines
NCT07272122 phase3recruitingnot on this mapstarted 2026, after this paper: background citation

Reducing Filth Fly Populations and Transmission of Diarrhoeal Pathogens in Harsh Settings: a Cross-over Trial in South Sudan

TypeinterventionalSponsorThe Mentor InitiativeRan2026 to 2027Enrolled5,556ConditionsDiarrheal DiseasesArmsBaited fly traps - iCatchi® ProMax fly traps, Insect growth regulator (IGR) - effervescent granule containing 2% diflubenzuron (20g/kg)
3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Sealant retention, patient satisfaction, and operator preference: a split-mouth randomised controlled trial comparing EasyPrepEuropean archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2026
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors.

An-Wen ChanDepartment of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-4498-3382
Isabelle BoutronUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.ORCID https://orcid.org/0000-0002-5263-6241
Sally HopewellOxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-6881-6984
David MoherCentre for Journalology, Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0003-2434-4206
Kenneth F SchulzDepartment of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0003-2596-7616
Gary S CollinsUK EQUATOR Centre, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-2772-2316
Ruth TunnOxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-1187-1808
Rakesh AggarwalJawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.ORCID https://orcid.org/0000-0001-9689-494X
Michael BerkwitsOffice of Science Dissemination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jesse A BerlinDepartment of Biostatistics and Epidemiology, School of Public Health, Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Brunswick, New Jersey, United States of America.ORCID https://orcid.org/0000-0002-9810-745X
Nita BhandariCentre for Health Research and Development, Society for Applied Studies, New Delhi, India.ORCID https://orcid.org/0000-0003-0349-087X
Nancy J ButcherChild Health Evaluation Services, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-5152-0108
Marion K CampbellAberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, United Kingdom.ORCID https://orcid.org/0000-0001-5386-4097
Runcie C W ChidebeProject PINK BLUE-Health & Psychological Trust Centre, Utako, Abuja, Nigeria.
Diana R ElbourneDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0003-3044-4545
Andrew J FarmerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-6170-4402
Dean A FergussonOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID https://orcid.org/0000-0002-3389-2485
Robert M GolubDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID https://orcid.org/0009-0000-3270-0632
Steven N GoodmanDepartment of Epidemiology and Population Health, Stanford University, Palo Alto, California, United States of America.ORCID https://orcid.org/0000-0002-3872-5723
Tammy C HoffmannInstitute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, University Drive, Robina, Queensland, Australia.ORCID https://orcid.org/0000-0001-5210-8548
John P A IoannidisDepartments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America.ORCID https://orcid.org/0000-0003-3118-6859
Brennan C KahanMRC Clinical Trials Unit at University College London, London, United Kingdom.
Rachel L KnowlesUniversity College London, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.ORCID https://orcid.org/0000-0002-5490-7682
Sarah E LambNIHR Exeter Biomedical Research Centre, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.ORCID https://orcid.org/0000-0003-4349-7195
Steff LewisEdinburgh Clinical Trials Unit, Usher Institute-University of Edinburgh, Edinburgh BioQuarter, Edinburgh, United Kingdom.
Elizabeth LoderThe BMJ, BMA House, London, United Kingdom.
Martin OffringaChild Health Evaluation Services, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-4402-5299
Philippe RavaudUniversité Paris Cité, Inserm, INRAE, Centre de Recherche Epidémiologie et Statistiques, Université Paris Cité, Paris, France.
Dawn P RichardsClinical Trials Ontario, MaRS Centre, Toronto, Ontario, Canada.
Frank W RockholdDuke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
David L SchrigerDepartment of Emergency Medicine, University of California, Los Angeles, California, United States of America.
Nandi L SiegfriedSouth African Medical Research Council, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-4081-1698
Sophie StaniszewskaWarwick Applied Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom.ORCID https://orcid.org/0000-0002-7723-9074
Rod S TaylorMRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.ORCID https://orcid.org/0000-0002-3043-6011
Lehana ThabaneDepartment of Health Research Methods Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
David J TorgersonYork Trials Unit, Department of Health Sciences, University of York, York, United Kingdom.
Sunita VohraFaculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0002-6210-7933
Ian R WhiteMRC Clinical Trials Unit at University College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-6718-7661
Asbjørn HróbjartssonCentre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.ORCID https://orcid.org/0000-0002-2451-5012

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceThe protocol of a randomised trial is the foundation for study planning, conduct, reporting, and external review. However, trial protocols vary in their completeness and often do not address key elements of design and conduct. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement was first published in 2013 as guidance to improve the completeness of trial protocols. Periodic updates incorporating the latest evidence and best practices are needed to ensure that the guidance remains relevant to users.

objectiveTo systematically update the SPIRIT recommendations for minimum items to address in the protocol of a randomised trial.

designWe completed a scoping review and developed a project specific database of empirical and theoretical evidence to generate a list of potential changes to the SPIRIT 2013 checklist. The list was enriched with recommendations provided by lead authors of existing SPIRIT/CONSORT (Consolidated Standards of Reporting Trials) extensions (Harms, Outcomes, Non-pharmacological Treatment) and other reporting guidelines (TIDieR). The potential modifications were rated in a three-round Delphi survey followed by a consensus meeting.

findingsOverall, 317 individuals participated in the Delphi consensus process and 30 experts attended the consensus meeting. The process led to the addition of two new protocol items, revision to five items, deletion/merger of five items, and integration of key items from other relevant reporting guidelines. Notable changes include a new open science section, additional emphasis on the assessment of harms and description of interventions and comparators, and a new item on how patients and the public will be involved in trial design, conduct, and reporting. The updated SPIRIT 2025 statement consists of an evidence-based checklist of 34 minimum items to address in a trial protocol, along with a diagram illustrating the schedule of enrolment, interventions, and assessments for trial participants. To facilitate implementation, we also developed an expanded version of the SPIRIT 2025 checklist and an accompanying explanation and elaboration document. CONCLUSIONS AND RELEVANCE: Widespread endorsement and adherence to the updated SPIRIT 2025 statement have the potential to enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, funders, research ethics committees, journals, trial registries, policymakers, regulators, and other reviewers.

Indexed as

Randomized Controlled Trials as TopicResearch DesignChecklistDelphi TechniqueHumans

Identifiers

PMID40294521
PMCPMC12037212

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.